NCT05525689

Brief Summary

Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

September 12, 2025

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

1.8 years

First QC Date

August 8, 2022

Results QC Date

September 8, 2025

Last Update Submit

September 11, 2025

Conditions

Keywords

Perinatal

Outcome Measures

Primary Outcomes (1)

  • Depression

    Assessed by Patient Health Questionnaire-9 Scores range from 0-27. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.

    At 12 weeks

Secondary Outcomes (2)

  • Anxiety

    At 12 weeks

  • Satisfaction Index - Mental Health

    Week 6, Week 12

Other Outcomes (2)

  • TWente Engagement With Ehealth Technologies Scale (TWEETS)

    Week 6, Week 12

  • Execution of Stepped Care

    Up to 12 weeks

Study Arms (2)

Technology Enabled Service

EXPERIMENTAL

Access to the Intellicare suite of digital mental health self-management tools and coaching

Behavioral: IntelliCare

eTreatment as Usual

ACTIVE COMPARATOR

Current care plus access to a website that will provide content specific to perinatal depression

Other: COMPASS-Care

Interventions

IntelliCareBEHAVIORAL

Application with patient-facing tools for depression symptom monitoring, self-management, and care manager communication as well as care manager dashboards for workflow optimization

Technology Enabled Service

Website with content specific to perinatal depression and standard EHR-based tools for patient communication

eTreatment as Usual

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • years or older
  • Referred to Northwestern Medicine COMPASS program for mental health care
  • Currently pregnant or within 3 months of delivery
  • Moderate to severe perinatal depression (defined as a PHQ-9 screen greater than or equal to 10)
  • Owns a smartphone, has used smartphone in last 7 days

You may not qualify if:

  • Experienced a pregnancy loss (miscarriage, termination, or stillbirth of the index pregnancy)
  • Severe suicidality (as defined by the presence of a plan and intent to act on that plan)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prentice Women's Hospital

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Dr. David Mohr
Organization
Northwestern University

Study Officials

  • David Mohr

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 8, 2022

First Posted

September 1, 2022

Study Start

June 16, 2022

Primary Completion

April 15, 2024

Study Completion

April 15, 2024

Last Updated

September 12, 2025

Results First Posted

September 12, 2025

Record last verified: 2025-09

Locations